Developer docs
API playgroundTry for free, no card

Search company profiles

MiCare Path

Full company profile

uuid0002uvc

Namestring
MiCare Path
Legal namestring
MiCare Path
Websiteurl
MiCarePath.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

MiCare Path is a Memphis, Tennessee-based virtual care company founded in 2019 that operates an AI-powered Remote Patient Monitoring (RPM) platform extending clinical care beyond office visits into patients' daily lives. The core MiCare Path Platform connects patients and providers through a patient-facing MiCare App and health-monitoring devices that capture continuous time-series data — blood pressure, heart rate, weight/BMI, blood glucose, and activity levels — supporting chronic condition management, cardiac monitoring, and data-driven clinical decision making. The company has integrated with device manufacturers, most notably a strategic partnership with BIOTRONIK that couples the BIOMONITOR IV insertable cardiac monitor with MiCare Path's RPM infrastructure to deliver turnkey cardiac monitoring programs for cardiology practices.

The company generates revenue through subscription/recurring RPM services billed primarily to healthcare providers and payers, operating on a quote-based, non-publicly-disclosed pricing model. Its go-to-market is sales-led, using direct enterprise field sales with 'Request a demo' CTAs on its website to target healthcare providers, payers, and patient populations with chronic conditions across the United States. Channel distribution is augmented through partnerships such as BIOTRONIK for cardiology.

MiCare Path serves a multi-segment customer base: clinicians and healthcare practices seeking continuous visibility into patient health between visits, payers seeking improved outcomes and cost reduction through remote monitoring, and patients with chronic conditions requiring ongoing monitoring at home. The company has completed four funding rounds — most recently in November 2025 — and acquired Compwell, LLC (a Tennessee-based care management and virtual assessments provider) in the same month to broaden its virtual care management capabilities and accelerate national U.S. expansion. Headcount is in the 11–50 range, and the company remains privately held.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMemphis, United States
HQ citystring
Memphis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, virtual care platform, chronic care management, healthcare technology, cardiac monitoring
Industry4 codes
SECONDARYHLALAFAL
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAH
Virtual Nursing, Telemonitoring & Command Center Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAFAEAN
Home Health Remote Patient Monitoring & Virtual Nursing Providers
NAICS code3 codes
  • Nursing Care Facilities (Skilled Nursing Facilities)623110
  • Services for the Elderly and Persons with Disabilities624120
  • Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly62331
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Home Health Care Services8082
Product category
Remote Patient Monitoring Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Remote Patient Monitoring Services
TypeSubscription Recurring
Description

MiCare Path generates revenue through its remote patient monitoring platform, providing continuous health monitoring services to healthcare providers. The platform supports billing for clinicians while delivering data-driven care for patients with chronic conditions, enabling value-based care models.

micarepath.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

MiCare Path provides an AI-powered virtual care platform centered on Remote Patient Monitoring (RPM) that extends care beyond office visits into patients' daily lives. The platform combines the MiCare App, health monitoring devices, and a provider-facing dashboard to enable continuous tracking of vital signs for chronic and cardiac conditions. Through its acquisition of Compwell, LLC, MiCare Path also delivers care management and virtual assessments services to clinicians and healthcare systems.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MiCare Path is a virtual care solutions platform offering an integrated ecosystem centered on Remote Patient Monitoring (RPM). The core MiCare Path Platform connects patients and providers through the MiCare App and health monitoring devices, enabling continuous care beyond office visits. The platform monitors vital signs including blood pressure, heart rate, weight/BMI, blood glucose, and activity levels. Through the acquisition of Compwell, LLC in November 2025, MiCare Path expanded its care management and virtual assessments capabilities to enhance chronic condition support. The platform is AI-powered to support clinicians with data-driven care decisions and improved patient outcomes.

Product and service1 record
1MiCare Path Platform
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-09
Description

BIOTRONIK Inc. formed a strategic partnership with MiCare Path to deliver a comprehensive remote physiologic monitoring program for cardiology practices in the United States. The collaboration combines BIOTRONIK's BIOMONITOR IV insertable cardiac monitor with MiCare Path's RPM platform and devices. This partnership enables clinics to extend cardiac care beyond office visits and improve patient outcomes, providing a turnkey solution for cardiology providers seeking to launch or expand cardiac monitoring programs.

2Compwell, LLC
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-25
Description

MiCare Path acquired Compwell, LLC, a Tennessee-based care management and virtual assessments provider. The acquisition accelerates MiCare Path's national expansion and AI-driven care initiatives. Compwell provides virtual assessments capabilities that complement MiCare Path's remote monitoring platform, enabling broader remote monitoring and care management services for patients with chronic conditions.

hospitalmanagement.net
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Broad telehealth incumbent with virtual care, chronic-condition, and RPM-adjacent capabilities; competes indirectly for the same provider and payer virtual-care budgets as MiCare Path.

TypeDirect peer
Description

A direct competitor offering an RPM and virtual care platform for chronic-condition management, with similar device-agnostic monitoring and provider-payer-patient workflows comparable to MiCare Path's offering.

3Health Recovery Solutions (HRS)
TypeDirect peer
Description

Direct RPM peer providing remote patient monitoring kits and a clinician dashboard across multiple chronic conditions, closely mirroring MiCare Path's device-plus-platform model.

TypeDirect peer
Description

A direct RPM competitor delivering cellular-enabled devices and a care management platform for providers and payers, overlapping with MiCare Path's recurring subscription RPM service.

TypeDirect peer
Description

Direct RPM peer offering remote patient monitoring devices, software, and clinician support services, targeting similar provider and value-based-care customers as MiCare Path.

TypeDirect peer
Description

RPM provider distributing connected devices and a clinician platform for continuous remote monitoring of chronic patients, directly comparable to MiCare Path's device-plus-platform approach.

7Biofourmis
TypeDirect peer
Description

AI-powered RPM and virtual care platform with predictive analytics for chronic and post-acute care; comparable to MiCare Path's AI-driven care initiatives and multi-condition monitoring.

TypeEmerging player
Description

An emerging RPM and chronic care management platform focused on physician practices, with overlapping chronic-condition use cases but smaller scale than MiCare Path.

TypeEmerging player
Description

Cellular RPM device supplier and platform provider; partial overlap with MiCare Path as a potential device partner/competitor in the RPM device-plus-software stack.

TypeBroad incumbent
Description

Established digital chronic-condition management provider addressing diabetes, hypertension, and behavior change; broader in scope than MiCare Path but competes for the same chronic-care payer and provider dollars.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MiCare Path

Remote Patient Monitoring PlatformMiCarePath.com

What MiCare Path does

MiCare Path is a Memphis, Tennessee-based virtual care company founded in 2019 that operates an AI-powered Remote Patient Monitoring (RPM) platform extending clinical care beyond office visits into patients' daily lives. The core MiCare Path Platform connects patients and providers through a patient-facing MiCare App and health-monitoring devices that capture continuous time-series data — blood pressure, heart rate, weight/BMI, blood glucose, and activity levels — supporting chronic condition management, cardiac monitoring, and data-driven clinical decision making. The company has integrated with device manufacturers, most notably a strategic partnership with BIOTRONIK that couples the BIOMONITOR IV insertable cardiac monitor with MiCare Path's RPM infrastructure to deliver turnkey cardiac monitoring programs for cardiology practices.

The company generates revenue through subscription/recurring RPM services billed primarily to healthcare providers and payers, operating on a quote-based, non-publicly-disclosed pricing model. Its go-to-market is sales-led, using direct enterprise field sales with 'Request a demo' CTAs on its website to target healthcare providers, payers, and patient populations with chronic conditions across the United States. Channel distribution is augmented through partnerships such as BIOTRONIK for cardiology.

MiCare Path serves a multi-segment customer base: clinicians and healthcare practices seeking continuous visibility into patient health between visits, payers seeking improved outcomes and cost reduction through remote monitoring, and patients with chronic conditions requiring ongoing monitoring at home. The company has completed four funding rounds — most recently in November 2025 — and acquired Compwell, LLC (a Tennessee-based care management and virtual assessments provider) in the same month to broaden its virtual care management capabilities and accelerate national U.S. expansion. Headcount is in the 11–50 range, and the company remains privately held.

MiCare Path firmographics

Firmographics
Name
MiCare Path
Legal name
MiCare Path
Website
https://MiCarePath.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where MiCare Path is headquartered

Location

Headquarters

HQ city
Memphis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MiCare Path business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Remote Patient Monitoring Services: MiCare Path generates revenue through its remote patient monitoring platform, providing continuous health monitoring services to healthcare providers. The platform supports billing for clinicians while delivering data-driven care for patients with chronic conditions, enabling value-based care models.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

MiCare Path product offering

Product offering

Core offering

MiCare Path provides an AI-powered virtual care platform centered on Remote Patient Monitoring (RPM) that extends care beyond office visits into patients' daily lives. The platform combines the MiCare App, health monitoring devices, and a provider-facing dashboard to enable continuous tracking of vital signs for chronic and cardiac conditions. Through its acquisition of Compwell, LLC, MiCare Path also delivers care management and virtual assessments services to clinicians and healthcare systems.

Product overview

MiCare Path is a virtual care solutions platform offering an integrated ecosystem centered on Remote Patient Monitoring (RPM). The core MiCare Path Platform connects patients and providers through the MiCare App and health monitoring devices, enabling continuous care beyond office visits. The platform monitors vital signs including blood pressure, heart rate, weight/BMI, blood glucose, and activity levels. Through the acquisition of Compwell, LLC in November 2025, MiCare Path expanded its care management and virtual assessments capabilities to enhance chronic condition support. The platform is AI-powered to support clinicians with data-driven care decisions and improved patient outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

  • MiCare Path Platform

Companies that use MiCare Path

Customer profile

Segments4 records

Ideal customer profiles3 records

MiCare Path technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature3 records

MiCare Path partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • BIOTRONIKcoreStrategic or Co-development Partner · 9 March 2026BIOTRONIK Inc. formed a strategic partnership with MiCare Path to deliver a comprehensive remote physiologic monitoring program for cardiology practices in the United States. The collaboration combines BIOTRONIK's BIOMONITOR IV insertable cardiac monitor with MiCare Path's RPM platform and devices. This partnership enables clinics to extend cardiac care beyond office visits and improve patient outcomes, providing a turnkey solution for cardiology providers seeking to launch or expand cardiac monitoring programs.
  • Compwell, LLCcoreTechnology or Integration · 25 November 2025MiCare Path acquired Compwell, LLC, a Tennessee-based care management and virtual assessments provider. The acquisition accelerates MiCare Path's national expansion and AI-driven care initiatives. Compwell provides virtual assessments capabilities that complement MiCare Path's remote monitoring platform, enabling broader remote monitoring and care management services for patients with chronic conditions.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

MiCare Path competitors and assessment

Company assessment

Broad incumbents

  • Teladoc Health: Broad telehealth incumbent with virtual care, chronic-condition, and RPM-adjacent capabilities; competes indirectly for the same provider and payer virtual-care budgets as MiCare Path.
  • Omada Health: Established digital chronic-condition management provider addressing diabetes, hypertension, and behavior change; broader in scope than MiCare Path but competes for the same chronic-care payer and provider dollars.

Direct peers

  • Vivify Health: A direct competitor offering an RPM and virtual care platform for chronic-condition management, with similar device-agnostic monitoring and provider-payer-patient workflows comparable to MiCare Path's offering.
  • Health Recovery Solutions (HRS): Direct RPM peer providing remote patient monitoring kits and a clinician dashboard across multiple chronic conditions, closely mirroring MiCare Path's device-plus-platform model.
  • CareSimple: A direct RPM competitor delivering cellular-enabled devices and a care management platform for providers and payers, overlapping with MiCare Path's recurring subscription RPM service.
  • Prevounce Health: Direct RPM peer offering remote patient monitoring devices, software, and clinician support services, targeting similar provider and value-based-care customers as MiCare Path.
  • 100Plus: RPM provider distributing connected devices and a clinician platform for continuous remote monitoring of chronic patients, directly comparable to MiCare Path's device-plus-platform approach.
  • Biofourmis: AI-powered RPM and virtual care platform with predictive analytics for chronic and post-acute care; comparable to MiCare Path's AI-driven care initiatives and multi-condition monitoring.

Emerging players

  • HealthArc: An emerging RPM and chronic care management platform focused on physician practices, with overlapping chronic-condition use cases but smaller scale than MiCare Path.
  • Smart Meter: Cellular RPM device supplier and platform provider; partial overlap with MiCare Path as a potential device partner/competitor in the RPM device-plus-software stack.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

MiCare Path social profiles

Digital presence

MiCare Path financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MiCare Path leadership team

Management profile

Number of profiles

Profiles3 records

MiCare Path subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

MiCare Path funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MiCare Path M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MiCare Path

What does MiCare Path do?

MiCare Path provides an AI-powered virtual care platform centered on Remote Patient Monitoring (RPM) that extends care beyond office visits into patients' daily lives. The platform combines the MiCare App, health monitoring devices, and a provider-facing dashboard to enable continuous tracking of vital signs for chronic and cardiac conditions. Through its acquisition of Compwell, LLC, MiCare Path also delivers care management and virtual assessments services to clinicians and healthcare systems.

Is MiCare Path a public or private company?

MiCare Path is a private company. It is classified as venture growth investor backed and is currently operating.

When was MiCare Path founded?

MiCare Path was founded in 2019. It employs 11 to 50 people.

Where is MiCare Path based?

MiCare Path is headquartered in Memphis, United States, in the North America region.

How does MiCare Path make money?

One revenue line is on record: remote Patient Monitoring Services.

Who are MiCare Path's main competitors?

Broad incumbents on record are Teladoc Health and Omada Health. Direct peers are Vivify Health, Health Recovery Solutions (HRS), CareSimple, Prevounce Health, 100Plus and Biofourmis. Emerging players are HealthArc and Smart Meter.

Does MiCare Path have an API?

No public API is recorded for MiCare Path.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magBIOTRONIK, MiCare Path Collaborate on Personalized Cardiac CareBIOTRONIK Inc. has formed a strategic partnership with MiCare Path to deliver a comprehensive remote physiologic monitoring program for cardiology practices in the United States. The collaboration combines BIOTRONIK's BIOMONITOR IV insertable cardiac monitor with MiCare Path's RPM platform and devices, enabling clinics to extend cardiac care beyond office visits and improve patient outcomes. The partnership is designed to provide a turnkey solution for cardiology providers seeking to launch or expand cardiac monitoring programs.Pulse 2.0MiCare Path: New Funding Raised And Compwell Acquired To Expand National Virtual Care PlatformMiCare Path announced the close of its fourth funding round alongside the acquisition of Tennessee-based Compwell, a provider of virtual assessments and care management services. The combined move is designed to strengthen MiCare Path's national virtual care platform, enhance its clinical programs with AI-driven tools, and improve operational efficiency for clinicians and health systems serving tens of thousands of patients. The company stated the capital will support continued innovation on its FDA-registered software platform and expand collaboration with hospitals and clinics as healthcare organizations shift toward value-based care models.Hospital ManagementMiCare Path acquires US care management provider CompwellMiCare Path has acquired US-based care management and virtual assessments provider Compwell and closed its fourth funding round. The acquisition accelerates MiCare Path's national expansion and enhances its AI-driven care capabilities on its FDA-registered software platform, which supports remote therapeutic monitoring, remote patient monitoring, and chronic care management. The company aims to extend care beyond office visits into patients' everyday lives through its integrated virtual care platform operating across 12 medical specialties.LinkedInMiCare Path Closes Fourth Funding Round and Acquires Compwell, LLC to Accelerate National Expansion and AI-Powered Virtual CareMiCare Path closed its fourth funding round and acquired Compwell, LLC to enhance its remote monitoring and care management services. These developments support the company's expansion efforts across the United States and aim to improve outcomes for patients with chronic conditions.FinSMEsMiCare Path Closes Fourth Funding Round; Acquires CompwellMiCare Path, a Memphis-based virtual care solutions company, closed its fourth funding round with undisclosed backers and announced the acquisition of Compwell, LLC, a Tennessee-based provider of care management and virtual assessments. The company intends to use the funds to expand operations and development efforts and to integrate Compwell's capabilities into its reimbursable virtual care platform. Founded in 2019 with 40 employees, MiCare Path serves patients across medical specialties nationwide through clinician partnerships.VC News DailyMiCare Path Announces Additional FundingMiCare Path, a Memphis-based virtual care solutions company, announced the successful close of its fourth funding round and the strategic acquisition of Compwell, LLC, a provider of care management and virtual assessments. Together, these milestones represent a pivotal step in MiCare Path's mission to transform connected, ongoing care delivery within the U.S. Founded in 2019, the company partners with physician groups, healthcare systems, and hospitals to deliver remote monitoring and care management.PR NewswireMiCare Path Closes Fourth Funding Round and Acquires Compwell, LLC to Accelerate National Expansion and AI-Powered Virtual CareMiCare Path closed its fourth funding round and acquired Compwell, LLC to accelerate national expansion of its AI-powered virtual care platform. This strategic move aims to deepen collaboration with health systems and enhance clinical efficiency through advanced technology integration.American City Business JournalsSBA 2024 finalist: MiCare Path fast-tracked its health care techMiCare Path, a virtual care navigation platform, was named a 2024 Small Business Awards finalist. The company reported 870% growth in active patients and a 338% increase in customers since its 2019 launch. It plans to build on its go-to-market strategy in fee-for-service outpatient clinics and aim for full sustainability by early 2025.